Table 2.
Multivariable logistic regression analyses to explain anxiety and depression
| Anxiety adjusted OR (95% CI)* | Depression adjusted OR (95% CI)† | |
| Age group | ||
| Adolescent | 0.43 (0.27 to 0.68) | – |
| Adult | Reference | – |
| Gender | ||
| Female | 1.75 (1.56 to 2.64) | – |
| Male | Reference | – |
| Age of asthma diagnosis | – | 1.03 (1.01 to 1.05) |
| Number of physician-reported comorbidities | 1.17 (0.99 to 1.37) | 1.31 (1.05 to 1.64) |
| CARAT T | 0.98 (0.94 to 1.00) | – |
| Quality of life (EQ-5D total) | – | 0.97 (0.95 to 0.99) |
| Perception of better health (EQ-5D VAS) | 0.97 (0.95 to 0.98) | 0.97 (0.96 to 0.99) |
| R2 | 22% | 23% |
| Hosmer-Lemeshow test—p value | 0.435 | 0.449 |
*Age, current occupation, setting, age of asthma diagnosis, GINA assessment of symptom control and quality of life (EQ-5D total) were also tested but not included in the final adjusted model.
†Age, age group, educational level, marital status, current occupation, BMI, GINA assessment of symptom control and CARAT-T were also tested but not included in the final adjusted model.
BMI, body mass index; CARAT-T, Control of Allergic Rhinitis and Asthma Test total score; EQ-5D, European Quality of Life Five Dimension Questionnaire; VAS, visual analogue scale.